Protagonist Therapeutics, Inc. (PTGX)
150.61
-0.89
(-0.59%)
USD |
NASDAQ |
Aug 27, 14:33
Protagonist Therapeutics Total Return Level : 151.50 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 151.50 |
| August 25, 2026 | 150.59 |
| August 24, 2026 | 154.72 |
| August 21, 2026 | 154.32 |
| August 20, 2026 | 150.69 |
| August 19, 2026 | 154.94 |
| August 18, 2026 | 157.34 |
| August 17, 2026 | 158.62 |
| August 14, 2026 | 155.10 |
| August 13, 2026 | 151.42 |
| August 12, 2026 | 152.01 |
| August 11, 2026 | 148.29 |
| August 10, 2026 | 150.00 |
| August 07, 2026 | 145.87 |
| August 06, 2026 | 146.18 |
| August 05, 2026 | 137.32 |
| August 04, 2026 | 135.81 |
| August 03, 2026 | 132.28 |
| July 31, 2026 | 136.64 |
| July 30, 2026 | 138.64 |
| July 29, 2026 | 133.00 |
| July 28, 2026 | 136.84 |
| July 27, 2026 | 135.56 |
| July 24, 2026 | 136.11 |
| July 23, 2026 | 135.43 |
| Date | Value |
|---|---|
| July 22, 2026 | 135.44 |
| July 21, 2026 | 138.31 |
| July 20, 2026 | 134.27 |
| July 17, 2026 | 140.91 |
| July 16, 2026 | 132.02 |
| July 15, 2026 | 135.46 |
| July 14, 2026 | 131.27 |
| July 13, 2026 | 129.89 |
| July 10, 2026 | 131.42 |
| July 09, 2026 | 137.64 |
| July 08, 2026 | 140.07 |
| July 07, 2026 | 140.85 |
| July 06, 2026 | 131.50 |
| July 02, 2026 | 131.62 |
| July 01, 2026 | 125.17 |
| June 30, 2026 | 122.58 |
| June 29, 2026 | 121.63 |
| June 26, 2026 | 121.88 |
| June 25, 2026 | 122.63 |
| June 24, 2026 | 122.15 |
| June 23, 2026 | 118.96 |
| June 22, 2026 | 115.03 |
| June 18, 2026 | 112.86 |
| June 17, 2026 | 111.44 |
| June 16, 2026 | 110.64 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 215.83 |
| Insmed, Inc. | 124.39 |
| Madrigal Pharmaceuticals, Inc. | 538.88 |
| AbbVie, Inc. | 452.85 |
| PTC Therapeutics, Inc. | 72.69 |